Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenal Gland Neoplasms × olaparib × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 4 Thymoma 1 Pheochromocytoma 1 Paraganglioma 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1 Carcinoid Tumor 1 Adrenal Gland Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 2 Fluorodeoxyglucose F18 2 FAPI-46 2 pertuzumab 1 olaparib 1 lutetium Lu 177 dotatate 1 Nivolumab 1 Erlotinib Hydrochloride 1 Cryosurgery 1 (18F)GTP1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06607692 2024-10-21

LUPARPED

Fundación de investigación HM

Phase 2 Recruiting

CNSEndocrineNET

Adrenal Gland Neoplasms, Medulloblastoma, Meningioma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡